HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV
A. Milewska, Y. Chi, A. Szczepanski, E. Barreto-Duran, K. Liu, D. Liu, X. Guo, Y. Ge, J. Li, L. Cui, M. Ochman, M. Urlik, S. Rodziewicz-Motowidlo, F. Zhu, K. Szczubialka, , K. Pyrc
This paper evaluates HTCC as a potential inhibitor for SARS-CoV-2 and MERS-CoV, highlighting its antiviral activity against highly pathogenic coronaviruses.
bioRxiv · Mar 29, 2020 · PreprintMicrobiology